DIMENSIONAL FUND ADVISORS LP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,101,741
+22.6%
3,978,385
+89.7%
0.01%
+20.0%
Q2 2023$14,762,990
+60.1%
2,097,003
+38.9%
0.01%
+66.7%
Q1 2023$9,221,577
+87250.4%
1,509,233
-8.7%
0.00%0.0%
Q4 2022$10,557
-99.9%
1,652,361
-0.6%
0.00%
-50.0%
Q3 2022$15,927,000
+15.7%
1,662,513
+33.3%
0.01%
+20.0%
Q2 2022$13,771,000
-29.6%
1,247,360
+6.2%
0.01%
-16.7%
Q1 2022$19,555,000
+15.8%
1,174,464
+32.8%
0.01%
+20.0%
Q4 2021$16,886,000
+107.0%
884,481
+167.3%
0.01%
+66.7%
Q3 2021$8,158,000
+79.9%
330,922
+89.9%
0.00%
+200.0%
Q2 2021$4,536,000
-24.9%
174,294
-8.8%
0.00%
-50.0%
Q1 2021$6,043,000
-6.1%
191,150
+37.8%
0.00%0.0%
Q4 2020$6,437,000
+99.7%
138,725
+41.7%
0.00%
+100.0%
Q3 2020$3,223,000
+75.2%
97,909
+46.1%
0.00%0.0%
Q2 2020$1,840,000
-86.9%
67,015
-85.7%
0.00%
-85.7%
Q1 2020$14,077,000
-34.4%
470,251
-39.3%
0.01%
-12.5%
Q4 2019$21,452,000
+44.7%
774,991
-4.9%
0.01%
+33.3%
Q3 2019$14,824,000
-25.9%
814,519
-0.2%
0.01%
-25.0%
Q2 2019$20,007,000
+489.1%
815,939
+128.5%
0.01%
+700.0%
Q1 2019$3,396,000
+7.4%
357,1280.0%0.00%0.0%
Q4 2018$3,161,000
+818.9%
357,128
+1067.2%
0.00%
Q3 2018$344,00030,5970.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders